Seguir
Eric Legius
Eric Legius
Hoogleraar Katholieke Universiteit Leuven
Dirección de correo verificada de telenet.be
Título
Citado por
Citado por
Año
SOX10 mutations in patients with Waardenburg-Hirschsprung disease
V Pingault, N Bondurand, K Kuhlbrodt, DE Goerich, MO Préhu, A Puliti, ...
Nature genetics 18 (2), 171-173, 1998
9201998
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)
CJ Gallione, GM Repetto, E Legius, AK Rustgi, SL Schelley, S Tejpar, ...
The Lancet 363 (9412), 852-859, 2004
7592004
The NF1 tumor suppressor critically regulates TSC2 and mTOR
CM Johannessen, EE Reczek, MF James, H Brems, E Legius, ...
Proceedings of the National Academy of Sciences 102 (24), 8573-8578, 2005
6232005
Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1–like phenotype
H Brems, M Chmara, M Sahbatou, E Denayer, K Taniguchi, R Kato, ...
Nature genetics 39 (9), 1120-1126, 2007
4762007
Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis
E Legius, DA Marchuk, FS Collins, TW Glover
Nature genetics 3 (2), 122-126, 1993
4531993
Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS.
A Swillen, K Devriendt, E Legius, B Eyskens, M Dumoulin, M Gewillig, ...
Journal of Medical Genetics 34 (6), 453-458, 1997
4061997
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
T De Raedt, E Beert, E Pasmant, A Luscan, H Brems, N Ortonne, K Helin, ...
Nature 514 (7521), 247-251, 2014
3982014
Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1
H Brems, E Beert, T de Ravel, E Legius
The lancet oncology 10 (5), 508-515, 2009
3642009
Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 Cognitive Disorders Task Force.
KN North, V Riccardi, C Samango-Sprouse, R Ferner, B Moore, E Legius, ...
Neurology, 1997
3291997
Elevated risk for MPNST in NF1 microdeletion patients
T De Raedt, H Brems, P Wolkenstein, D Vidaud, S Pilotti, F Perrone, ...
The American Journal of Human Genetics 72 (5), 1288-1292, 2003
3162003
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia
JR Hurvitz, WM Suwairi, W Van Hul, H El-Shanti, A Superti-Furga, ...
Nature genetics 23 (1), 94-98, 1999
3061999
PTPN11 mutations in LEOPARD syndrome
E Legius, C Schrander-Stumpel, E Schollen, C Pulles-Heintzberger, ...
Journal of medical genetics 39 (8), 571-574, 2002
2902002
Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients
E Claes, G Evers‐Kiebooms, A Boogaerts, M Decruyenaere, L Denayer, ...
American Journal of Medical Genetics Part A 116 (1), 11-19, 2003
2852003
Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients
O Maertens, H Prenen, M Debiec-Rychter, A Wozniak, R Sciot, P Pauwels, ...
Human molecular genetics 15 (6), 1015-1023, 2006
2612006
CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia
S Kohl, B Varsanyi, GA Antunes, B Baumann, CB Hoyng, H Jägle, ...
European Journal of Human Genetics 13 (3), 302-308, 2005
2412005
The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.
A Swillen, K Devriendt, E Legius, P Prinzie, A Vogels, P Ghesquière, ...
Genetic Counseling (Geneva, Switzerland) 10 (1), 79-88, 1999
2371999
Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders
A Vogels, J Van Den Ende, K Keymolen, G Mortier, K Devriendt, E Legius, ...
European Journal of Human Genetics 12 (3), 238-240, 2004
2222004
Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors
E Beert, H Brems, B Daniëls, I De Wever, F Van Calenbergh, ...
Genes, Chromosomes and Cancer 50 (12), 1021-1032, 2011
2152011
Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6
Q Zhang, B Zhao, W Li, N Oiso, EK Novak, ME Rusiniak, R Gautam, ...
Nature genetics 33 (2), 145-153, 2003
2072003
TP53 mutations are frequent in malignant NFI tumors
E Legius, H Dierick, R Wu, BK Hall, P Marynen, JJ Cassiman, TW Glover
Genes, Chromosomes and Cancer 10 (4), 250-255, 1994
2061994
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20